Mutation of proline 211 reduces shedding of the human p75 TNF receptor

Journal of Immunology

Volumn 160, Issue 5, 1998, Pages 2478-2487

  Herman, Charlotte ^a,b   Chernajovsky, Yuti ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROLINE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVE SITE; GENE DELETION; KIDNEY CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; CELL LINE; COS CELLS; HUMANS; LYMPHOMA, B-CELL; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; POINT MUTATION; PROLINE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SEQUENCE DELETION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032030670     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Bazil. V. 1995. Physiological enzymatic cleavage of leukocyte membrane molecules. Immumol. Today 16:135.
2. Ehlers, M. R., and J. F. Riordan. 1991. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 30:10065.
3. Rose-John, S., and P. C. Heinrich. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300:281.
4. Beutler, B., and A. Cerami. 1989. The biology of cachetin/TNF: a primary mediator of the host response. Annu. Rev. Immunol. 7:625.
5. Loetscher, H., Y. Pan, H. Lahm, R. Gentz, M. Brockhaus, H. Tabuchi, and W. Lesslauer. 1990. Molecular cloning and expression of the human 55kD tumour necrosis factor receptor. Cell 61:351-359.
6. Schall, T. J., M. Lewis, K. I. Koller, A. Lee, G. C. Rice, G. H. W. Wong, T. Gatanaga, G. A. Granger, R. Lentz, H. Raab, W. J. Kohr, and D. V. Goeddel. 1990. Molecular cloning and expression of a receptor for human tumour necrosis factor. Cell 61:361.
7. Gray, P., K. Barrett, D. Chantry, M. Turner, and M. Feldmann. 1990. Cloning of human tumour necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF binding protein. Proc. Natl. Acad. Sci. USA 87:7380.
8. Smith, C., T. Davis, D. Anderson, L. Solam, M. Beckmann, R. Jerzy, S. Dower, D. Cosman, and R. Goodwin. 1990. A receptor for tumour necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
9. Dembic, Z., H. Loetscher, U. Gubler, Y. Pan, H. Lahm, R. Gentz, M. Brockhaus, and W. Lesslauer. 1990. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231.
10. Lantz, M., U. Gullberg, E. Nilsson, and I. Olsson. 1990. Characterization in vitro of a human tumour necrosis factor binding protein, a soluble form of a tumour necrosis factor receptor. J. Clin. Invest. 86:1396.
11. Engelmann, H., D. Novick, and D. Wallach. 1990. Two tumour necrosis factor-binding proteins purified from human urine. J. Biol. Chem. 265:1531.
12. Khono, T., M. Brewer, S. Baker, P. Schwartz, M. King, K. Hale, C. Squires, R. Thompson, and J. Vannice. 1990. A second tumour necrosis factor receptor gene product can shed a naturally occurring tumour necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87:8331.
13. Gatanaga, T., C. Kwang, M. Gatanaga, F. Cappuccini, R. Yamamoto, and G. Granger. 1991. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA-and LPS-stimulated human monocytic THP-1 cells in vitro. Cell. Immunol. 138:1.
14. Porteu, F., and C. Nathan. 1990. Shedding of tumour necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172:599.
15. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors. J. Exp. Med. 175:323.
16. Brakebusch, C., E. E. Varfolomeev, M. Batkin, and D. Wallach. 1994. Structural requirements for inducible shedding of the p55 tumour necrosis factor receptor. J. Biol. Chem. 269:32488.
17. Fernandez-Botran, R., and E. Vitetta. 1990. A soluble, high affinity, interleukin-4-binding-protein is present in the biological fluids of mice. Proc. Natl. Acad. Sci. USA 87:4202.
18. Goodwin, R., D. Friend, S. Ziegler, R. Jerzy, B. Falk, S. Gimpel, D. Cosman, S. Dower, C. March, A. Namen, and L. Park. 1990. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941.
19. Kriegler, M., C. Perez, K. De Fay, I. Albert, and S. D. Lu. 1988. A novel form of TNF/cachetin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 53:45.
20. Nophar, Y., O. Kemper, C. Brakebusch, H. Engelmann, R. Zwang, D. Aderka, H. Holtmann, and D. Wallach. 1990. Soluble forms of tumour necrosis factor receptors (TNF-Rs): the cDNA for type 1 TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9:3269.
21. Perez, C., I. Albert, K. De Fay, N. Zachariades, L. Gooding, and M. Kriegler. 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63:251.
22. Gullberg, U., M. Lantz, L. Lindvall, I. Olsson, and A. Himmler. 1992. Involvement of an Asn/Val cleavage site in the production of a soluble form of human tumour necrosis factor (TNF) receptor: site directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain. Eur. J. Cell Biol. 58:307.
23. Porteu, F., M. Brockhaus, D. Wallach, H. Engelmann, and C. Nathan. 1991. Human neutrophil elastase releases a ligand binding fragment from the 75-kDa tumour necrosis factor (TNF) receptor. J. Biol. Chem. 266:18846.
24. Crowe, P. D., B. N. Walter, K. M. Mohler, C. Otten-Evans, R. A. Black, and C. F. Ware. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T-lymphocytes. J. Exp. Med. 181:1205.
25. Crowe, P., T. Van Arsdale, R. Goodwin, and C. Ware. 1993. Specific induction of 80-kDa tumour necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation. J. Immunol. 151:6882.
26. Pocsik, E., E. Duda, and D. Wallach. 1995. Phosphorylation of the 26 kDa TNF precursor in monocytic cells and in transfected HeLa cells. J. Inflamm. 45:152.
27. Kahn, J., R. I. Ingraham, F. Shirley, G. I. Migaki, and T. K. Kishimoto. 1994. Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin. J. Cell Biol. 125:461.
28. Van Wart, H. E., and D. R. Steinbrink. 1981. A continuous spectrophotometric assay for Clostridium histolyticum collagenase. Anal. Biochem. 113:356.
29. Leeuwenberg, J. F. M., T. M. A. A. Jeunhomme, and W. A. Buurman. 1994. Slow release of soluble TNF receptors by monocytes in vitro. J. Immunol. 152:4036.
30. Zeman, K., E. M. Paleolog, H. Tchorzewski, and B. Szymanska. 1993. Comparison of the functional activities of two different preparations of human recombinant tumour necrosis factor a. Arch. Immunol. Ther. Exp. 41:159.
31. Kunkel, T. A. 1987. Oligonucleotide-directed mutagenesis without phenotypic selection. In Current Protocols in Molecular Biology. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. Wiley Interscience, New York, pp. 8.1.1-8.1.6.
32. + thalassemia: aberrant splicing results from a single point mutant in an intron. Cell 27:289.
33. De Wet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and S. Subramani. 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725.
34. 131I-labelled human growth hormone of high specific radioactivity. Biochem. J. 89:114.
35. Chen, P. C. H., G. C. Du Bois, and M. J. Chen. 1995. Mapping the domains critical for the binding of human tumour necrosis factor a to its two receptors. J. Biol. Chem. 270:2874.
36. Porteu, F., and C. Hieblot. 1994. Tumour necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J. Biol. Chem. 269:2834.
37. Hwang, C., M. Gatanaga, G. Granger, and T. Gatanaga. 1993. mechanism of release of soluble forms of tumour necrosis factor/lymphotoxin receptors by phorbol myristate acetate stimulated human THP-1 cells in vitro. J. Immunol. 151:5631.
38. Robache-Gallea, S., V. Morand, J. M. Bruneau, B. Schoot, E. Tagat, E. Realo, S. Chuaib, and S. Roman-Roman. 1995. In vitro processing of human tumour necrosis factor α. J. Biol. Chem. 270:23688.
39. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370:555.
40. McGeehan, G., J. D. Becherer, R. C. Bast, C. M. Boyer, B. Champion, K. M. Connolly, J. G. Conway, P. Furdon, S. Karp, S. Kidao, A. B. McElroy, J. Nichols, K. M. Pryzwansky, F. Schoenen, L. Sekut, A. Truesdale, M. Verghese, J. Warner, and J. P. Ways. 1994. Regulation of tumour necrosis factor a processing by a metalloproteinase inhibitor. Nature 370:558.
41. Mohler, K. M., P. R. Sleath, J. N. Fitzner, D. P. Cerretti, M. Alderson, S. S. Kerwar, D. S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna, S. R. Kronheim, M. Peterson, M. Gerhan, C. J. Kozlosky, C. J. March, and R. A. Black. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218.
42. Mullberg, J., F. H. Durie, C. Otten-Evans, M. R. Alderson, S. Rose-John, D. Cosman, R. A. Black, and K. M. Mohler. 1995. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J. Immunol. 155:5198.
43. Williamson, M. P. 1994. The structure and function of proline-rich regions. Biochem. J. 297:249.
44. Dando, P. M., M. A. Brown, and A. J. Barrett. 1993. Human thimet oligopeptidase. Biochem. J. 294:451.
45. Barelli, H., J. Vincent, and F. Checler. 1993. Rat kidney endopeptidase 24.16: purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides. Eur. J. Biochem. 211:79.
46. Yoshimoto, T., T. Nishimura, T. Kita, and D. Tsuru. 1983. Post-proline cleaving enzyme (prolyl endopeptidase) from bovine brain. J. Biochem. 94:1179.
47. Migaki, G. L., J. Kahn, and T. K. Kishimoto. 1995. Mutational analysis of the membrane-proximal cleavage site of L-selectin: relaxed sequence specificity surrounding the cleavage site. J. Exp. Med. 182:549.
48. Joyce, D. A., D. P. Gibbons, P. Green, J. H. Steer, M. Feldmann, and F. M. Brennan. 1994. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumour necrosis factor receptor by cultured monocytes. Eur. J. Immunol. 24: 2699.
49. Williams, L., D. Gibbons, A. Gearing, R. Maini, M. Feldmann, and F. Brennan. 1996. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF a processing in RA synovial membrane cell cultures. J. Clin. Invest. 97:2833.
50. Black, R., F. Durie, C. Otten-Evans, R. Miller, J. Slack, D. Lynch, B. Castner, K. Mohler, M. Gerhart, R. Johnson, Y. Itoh, Y. Okada and H. Nagase. 1996. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem. Biophys. Res. Commun. 225:400.
51. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K. A. Schooley, M. Gerhart, R. Davis, J. N. Fitzner, R. S. Johnson, R. J. Paxton, C. J. March, and D. P. Cerretti. 1997. A metalloprotease disintegrin that releases tumour-necrosis factor a from cells. Nature 385:729.
52. Moss, M. L., S. L. C. Jin, M. E. Milla, W. Burkhart, H. L. Carter, W. J. Chen, W. C. Clay, J. R. Didsbury, D. Hassler, C. R. Hoffman, T. A. Kost, M. H. Lambert, M. A. Leesnitzer, P. McCauley, G. McGeehan, J. Mitchell, M. Moyer, G. Pahel, W. Rocque, L. K. Overton, F. Schoenen, T. Seaton, J. L. Su, J. Warner, D. Willard, and J. D. Becherer. 1997. Cloning of a disintegrin metalloprotease that processes precursor tumour-necrosis factor α. Nature 385:733.
53. Wolfsberg, T. G., P. Primakoff, D. G. Myles, and J. M. White. 1995. ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J. Cell Biol. 131:275.